Showing results (121-130 of 4,543) with videos related to
Sort By:
Pageof 455
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|May 21, 2021
[Tetrahedral Framework Nucleic Acids and Human Health]Yun-Feng LinHua Xi Kou Qiang Yi Xue Za Zhi = Huaxi Kouqiang Yixue Zazhi = West China Journal of Stomatology|December 3, 2021
Research progress on the application of framework nucleic acid in bone regenerationYun Feng LinJournal of Medical Systems|December 10, 2015
Chaotic Visual Cryptosystem Using Empirical Mode Decomposition Algorithm for Clinical EEG SignalsChin-Feng LinClinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 29, 2011
Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008Zobair M Younossi, Maria Stepanova, Mariam Afendy, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2015
The impact of ledipasvir/sofosbuvir on patient-reported outcomes in cirrhotic patients with chronic hepatitis C: the SIRIUS studyZobair M Younossi, Maria Stepanova, Stanislas Pol, et al.Hepatology (Baltimore, Md.)|March 2, 2011
Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortalityZobair M Younossi, Maria Stepanova, Nila Rafiq, et al.Biochemical and Biophysical Research Communications|November 5, 2013
Down-regulation of tripartite-motif containing 22 expression in breast cancer is associated with a lack of p53-mediated inductionYang Sun, Gay Hui Ho, Heng Nung Koong, et al.The Journal of Infectious Diseases|January 14, 2015
Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported OutcomesZobair M Younossi, Maria Stepanova, Mark Sulkowski, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 18, 2017
A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLDZobair M Younossi, Maria Stepanova, Linda Henry, et al.Frontiers in Immunology|April 18, 2022
Case Report: Multiple Causes of Cardiac Death After the First Infusion of Atezolizumab: Histopathological and Immunohistochemical FindingsEkaterina Kushnareva, Maria Stepanova, Elizaveta Artemeva, et al.Pageof 455